Gilead Partners With Tentarix In Platform Discovery Deal

Deal Snapshot: Gilead will collaborate with the start-up on the discovery and development of first-in-class targeted, multifunctional, conditional therapeutics.

multi target approach
Gilead partners on multi-target antibody technology • Source: Shutterstock

More from Deals

More from Business